Cedric Valentin

Speaker

Smart Engineering Project Manager, GlaxoSmithKline plc

Ambitious and accomplished engineering leader with over 25 years of experience in driving operational excellence and strategic initiatives within matrix and multicultural environments in the pharmaceutical industry. Proven expertise in leading global teams, optimizing asset, and delivering projects.

Certified in Advanced Asset Management, with a focus on Continuous Improvement, Engineering, Performance, Digitalization and Compliance. Adept at fostering innovation, enhancing productivity, and creating significant business value through strategic execution and delivery.

The Pop in Your Job: In my role at GSK, I deliver innovative smart engineering solutions across various sites, focusing on enhancing asset uptime, equipment reliability, maintenance effectiveness, manufacturing capacity, and overall productivity. What drives me is the opportunity to collaborate with diverse teams, making their daily tasks easier and more efficient. I am passionate about the impact of new technologies on improving people's work experiences. The connection with sites worldwide allows me to embrace different cultures and address unique needs. Working for GSK, a company dedicated to bettering and improving human health, aligns with my values and commitment to contributing to a healthier world.

Join Cedric Valentin
Book Now!

Sessions

The Future of Driving Maintenance Excellence & Empowering Pharmaceutical Success Through the Integration of AI

Panel Discussion

Monday, September 22

06:10 pm - 06:55 pm

Live in Berlin

Less Details

In this forward-looking panel, industry experts will explore how AI — including the emergence of agentic AI — is transforming maintenance practices across the pharmaceutical industry. As companies strive to achieve operational excellence at scale, AI is no longer limited to data analysis; it is evolving into an active participant in decision-making, orchestration, and continuous optimization. This discussion will examine how AI-driven systems, from predictive models to autonomous agents, are reshaping maintenance strategies — from asset lifecycle management to intelligent resource planning and adaptive operational support. Panelists will share practical insights into implementation, key learnings, and how they’re embracing the next evolution of AI to strengthen performance, compliance, and resilience across global sites. Learn more about:

How AI-powered tools — including emerging agentic systems — are enabling proactive and adaptive maintenance practices that reduce downtime and increase asset value.
Integrating AI into asset lifecycle management to automate decision support, optimize replacement strategies, and dynamically adapt to site-specific performance patterns.
Enhancing resource planning through AI agents that autonomously coordinate maintenance schedules, allocate resources in real time, and align capabilities with shifting operational needs.
Creating consistent operational support through AI-driven insights and decision agents that help maintain compliance, uphold quality standards, and enable rapid, localized action across decentralized sites.

Panel Discussion

How Can Digitalization and Generative AI Enhance Maintenance Efficiency, Streamline Operations, and Improve Preventative Maintenance?

(7) GEN AI Café

Tuesday, September 23

04:00 pm - 05:00 pm

Live in Berlin

Less Details

How can we make maintenance teams more digital while keeping their work easier and more efficient?
What are the biggest barriers to AI adoption in maintenance, and how can we address them?
How can generative AI enhance preventative maintenance and improve maintenance effectiveness?
In what ways can AI help link maintenance severity levels to better predict failures and reduce downtime?
How can AI help unify maintenance practices across different sites and languages?

Workshop

Company

GlaxoSmithKline plc

GSK is a global biopharma company with a mission to unite science, technology, and talent to get ahead of disease together. Our goal is to positively impact the health of 2.5 billion people by the end of the decade, fostering a thriving environment for our team. As a focused biopharma company, we specialize in preventing and treating diseases through specialty medicines, vaccines, and general medicines. Our research concentrates on the science of the immune system and advanced technologies, with significant investments in respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.Our Ahead Together strategy emphasizes early intervention to prevent and change the course of diseases, supporting people and healthcare systems. We aim to discover new, better medicines and vaccines while also preventing illnesses and mitigating their long-term impacts. Our robust portfolio and pipeline continue to grow, with key milestones achieved across our core therapeutic areas in 2023.Strategic partnerships, such as those with the University of Oxford on neurodegenerative diseases, Kings College London on cancer treatment, and 23andMe on genetics and genomics, are vital to our discovery efforts. Our culture at GSK is driven by a commitment to being ambitious for patients, accountable for impact, and doing the right thing, ensuring that GSK remains an exciting and inspiring place to work. Our Code outlines the commitments we uphold to achieve our goals and bring our culture to life, making GSK a place where people can thrive.

Get Agenda

Book Now